ZAI LAB (09688) Announces Grant of Share Options and Restricted Share Units

Bulletin Express03-05

Zai Lab (09688) stated that on March 2, 2026 (U.S. Eastern Time), the company granted 8,000 American depositary shares (ADSs) in share options, representing 80,000 underlying ordinary shares. The exercise price per ADS is US$19.48, and the options are valid for ten years. According to the announcement, 25% of the options will vest on each anniversary of the grant date over a four-year period, contingent on continued employment. No performance targets or clawback mechanisms apply to these grants.

In addition, the company granted 12,344 ADSs in restricted share units (RSUs), representing 123,440 underlying ordinary shares. The RSUs are set to vest at a rate of 25% each year over four years, also dependent on continued employment. Similar to the options, there are no performance requirements or clawback measures. The reasons cited for these grants include recognizing and rewarding contributions and providing added motivation to employees.

After these transactions, Zai Lab reported that 80.07 million shares remain available for future grants under the 2024 Equity Incentive Plan, which was approved at the company’s 2024 annual general meeting. The announcement highlighted that none of the grantees are directors, chief executives, or substantial shareholders of the company, and no party involved exceeds the individual or 12-month limit requirements set forth in the Listing Rules.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1178893482?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-05 23:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1178893482","market":"hk","top_or_hot":-1,"title":"ZAI LAB (09688) Announces Grant of Share Options and Restricted Share Units","media":"Bulletin Express","content":"<p>Zai Lab (09688) stated that on March 2, 2026 (U.S. Eastern Time), the company granted 8,000 American depositary shares (ADSs) in share options, representing 80,000 underlying ordinary shares. The exercise price per ADS is US$19.48, and the options are valid for ten years. According to the announcement, 25% of the options will vest on each anniversary of the grant date over a four-year period, contingent on continued employment. No performance targets or clawback mechanisms apply to these grants.</p>\n<p>In addition, the company granted 12,344 ADSs in restricted share units (RSUs), representing 123,440 underlying ordinary shares. The RSUs are set to vest at a rate of 25% each year over four years, also dependent on continued employment. Similar to the options, there are no performance requirements or clawback measures. The reasons cited for these grants include recognizing and rewarding contributions and providing added motivation to employees.</p>\n<p>After these transactions, Zai Lab reported that 80.07 million shares remain available for future grants under the 2024 Equity Incentive Plan, which was approved at the company’s 2024 annual general meeting. The announcement highlighted that none of the grantees are directors, chief executives, or substantial shareholders of the company, and no party involved exceeds the individual or 12-month limit requirements set forth in the Listing Rules.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ZAI LAB (09688) Announces Grant of Share Options and Restricted Share Units</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZAI LAB (09688) Announces Grant of Share Options and Restricted Share Units\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-05 23:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zai Lab (09688) stated that on March 2, 2026 (U.S. Eastern Time), the company granted 8,000 American depositary shares (ADSs) in share options, representing 80,000 underlying ordinary shares. The exercise price per ADS is US$19.48, and the options are valid for ten years. According to the announcement, 25% of the options will vest on each anniversary of the grant date over a four-year period, contingent on continued employment. No performance targets or clawback mechanisms apply to these grants.</p>\n<p>In addition, the company granted 12,344 ADSs in restricted share units (RSUs), representing 123,440 underlying ordinary shares. The RSUs are set to vest at a rate of 25% each year over four years, also dependent on continued employment. Similar to the options, there are no performance requirements or clawback measures. The reasons cited for these grants include recognizing and rewarding contributions and providing added motivation to employees.</p>\n<p>After these transactions, Zai Lab reported that 80.07 million shares remain available for future grants under the 2024 Equity Incentive Plan, which was approved at the company’s 2024 annual general meeting. The announcement highlighted that none of the grantees are directors, chief executives, or substantial shareholders of the company, and no party involved exceeds the individual or 12-month limit requirements set forth in the Listing Rules.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09688","symbol_name":"再鼎医药","start_time":0,"source_url":"","article_id":"1178893482","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1178893482","pubTimestamp":1772723152,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zai Lab (09688) stated that on March 2, 2026 (U.S. Eastern Time), the company granted 8,000 American depositary shares (ADSs) in share options, representing 80,000 underlying ordinary shares. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09688":"再鼎医药"},"translate_title":"再鼎医药(09688)公布授出购股权及受限制股份单位","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09688":1},"content_text":"Zai Lab (09688) stated that on March 2, 2026 (U.S. Eastern Time), the company granted 8,000 American depositary shares (ADSs) in share options, representing 80,000 underlying ordinary shares. The exercise price per ADS is US$19.48, and the options are valid for ten years. According to the announcement, 25% of the options will vest on each anniversary of the grant date over a four-year period, contingent on continued employment. No performance targets or clawback mechanisms apply to these grants.\nIn addition, the company granted 12,344 ADSs in restricted share units (RSUs), representing 123,440 underlying ordinary shares. The RSUs are set to vest at a rate of 25% each year over four years, also dependent on continued employment. Similar to the options, there are no performance requirements or clawback measures. The reasons cited for these grants include recognizing and rewarding contributions and providing added motivation to employees.\nAfter these transactions, Zai Lab reported that 80.07 million shares remain available for future grants under the 2024 Equity Incentive Plan, which was approved at the company’s 2024 annual general meeting. The announcement highlighted that none of the grantees are directors, chief executives, or substantial shareholders of the company, and no party involved exceeds the individual or 12-month limit requirements set forth in the Listing Rules.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1178893482","isCrawlerRequest":true}